Melt blending of poly(lactic acid) with biomedically relevant polyurethanes to improve mechanical performance
- PMID: 38444474
- PMCID: PMC10912236
- DOI: 10.1016/j.heliyon.2024.e26268
Melt blending of poly(lactic acid) with biomedically relevant polyurethanes to improve mechanical performance
Abstract
Minimally invasive surgery procedures are of utmost relevance in clinical practice. However, the associated mechanical stress on the material poses a challenge for new implant developments. In particular PLLA, one of the most widely used polymeric biomaterials, is limited in its application due to its high brittleness and low elasticity. In this context, blending is a conventional method of improving the performance of polymer materials. However, in implant applications and development, material selection is usually limited to the use of medical grade polymers. The focus of this work was to investigate the extent to which blending poly-l-lactide (PLLA) with low contents of a selection of five commercially available medical grade polyurethanes leads to enhanced material properties. The materials obtained by melt blending were characterized in terms of their morphology and thermal properties, and the mechanical performance of the blends was evaluated taking into account physiological conditions. From these data, we found that mixing PLLA with Pellethane 80A is a promising approach to improve the material's performance, particularly for stent applications. It was found that PLLA/Pellethane blend with 10% polyurethane exhibits considerable plastic deformation before fracture, while pure PLLA fractures with almost no deformation. Furthermore, the addition of Pellethane only leads to a moderate reduction in elongation at yield and yield stress. In addition, dynamic mechanical analysis for three different PLLA/Pellethane ratios was performed to investigate thermally induced shape retention and shape recovery of the blends.
Keywords: PLLA; PLLA polyurethane blends; Polymer stent; Shape memory polymers.
© 2024 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures















References
-
- Kereiakes D.J., Ellis S.G., Metzger C., Caputo R.P., Rizik D.G., Teirstein P.S., Litt M.R., Kini A., Kabour A., Marx S.O., Popma J.J., McGreevy R., Zhang Z., Simonton C., Stone G.W. 3-Year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial. J. Am. Coll. Cardiol. 2017;70:2852–2862. doi: 10.1016/j.jacc.2017.10.010. - DOI - PubMed
-
- Raphael C.E., El-Sabbagh A., Corban M., Hajj S.E., Prasad A. In: Emerging Technologies for Heart Diseases: Volume 2: Treatments for Myocardial Ischemia and Arrhythmias. Nussinovitch U., editor. Elsevier Science & Technology; San Diego: 2020. Chapter 24 - emerging therapies in coronary balloon angioplasty, stenting, and bioabsorbable scaffolds; pp. 527–557.
-
- Mcmahon Sean, Bertollo N., Cearbhaill Eoin D. O’, Salber J., Pierucci Luca, Duffy Patrick, Durig T., Bi Vivian, Wang Wenxin. Bio-resorbable polymer stents: a review of material progress and prospects. Prog. Polym. Sci. 2018;83:79–96. doi: 10.1016/j.progpolymsci.2018.05.002. - DOI
-
- Bink N., Mohan V.B., Fakirov S. Recent advances in plastic stents: a comprehensive review. Int. J. Polym. Mater. 2021;70:54–74. doi: 10.1080/00914037.2019.1685519. - DOI
LinkOut - more resources
Full Text Sources